-

Bain Capital Specialty Finance, Inc. Announces March 31, 2026 Financial Results and Declares Second Quarter 2026 Dividend of $0.42 per Share

BOSTON--(BUSINESS WIRE)--Bain Capital Specialty Finance, Inc. (NYSE: BCSF, the “Company”, “our” or “we”) today announced financial results for the first quarter ended March 31, 2026, and that its Board of Directors (the “Board”) has declared a dividend of $0.42 per share for the second quarter of 2026.

"BCSF’s credit fundamentals remained sound across our portfolio with stable, low non-accruals and attractive net investment income that continued to cover our dividend,” said Michael Ewald, Chief Executive Officer of BCSF. “Despite market volatility and a challenging macroeconomic backdrop, we maintained a disciplined and selective approach to new investment activity, continuing to focus on structures that provide strong lender controls. Given Bain Capital’s longstanding presence and expertise in the core middle market, we believe BCSF remains well-positioned to navigate the current market environment through its predominantly first lien portfolio, broad diversification across industries, and durable balance sheet.”

Quarterly Highlights

  • Net investment income (NII) per share was $0.42, equating to an annualized NII yield on book value of 10.0%(1);
  • Net income per share was $0.05, equating to an annualized return on book value of 1.2%(1);
  • Net asset value per share as of March 31, 2026 was $16.86, as compared to $17.23 as of December 31, 2025;
  • Gross and net investment fundings were $243.2 million and $(12.2) million, respectively; ending net debt-to-equity was 1.28x, as compared to 1.24x as of December 31, 2025(2);
  • Investments on non-accrual represented 1.4% and 0.6% of the total investment portfolio at amortized cost and fair value, respectively, as of March 31, 2026, down from 1.5% and 0.8% of the total investment portfolio at amortized cost and fair value, respectively, as of December 31, 2025;
  • During the quarter, the Company closed an offering of $350.0 million aggregate principal amount of 5.950% unsecured notes due 2031 (the “March 2031 Notes”). In connection with these notes, the Company entered into an interest rate swap agreement to receive a fixed interest rate of 5.950% per annum and pay a floating interest rate of SOFR plus 2.28% per annum; and
  • Subsequent to quarter-end, the Company’s Board of Directors declared a dividend of $0.42 per share for the second quarter of 2026 payable to stockholders of record as of June 15, 2026(3).

Selected Financial Highlights

($ in millions, unless otherwise noted)

Q1 2026

 

Q4 2025

 

Net investment income per share

$

0.42

 

$

0.46

 

Net investment income

$

27.4

 

$

29.7

 

Earnings per share

$

0.05

 

$

0.43

 

Regular dividends per share declared and payable

$

0.42

 

$

0.42

 

Special dividends per share declared and payable

$

-

 

$

0.18

 

($ in millions, unless otherwise noted)

As of


March 31, 2026

 

As of


December 31, 2025

 

Total fair value of investments

$

2,470.8

 

$

2,508.4

 

Total assets

$

2,601.7

 

$

2,662.6

 

Total net assets

$

1,093.6

 

$

1,117.4

 

Net asset value per share

$

16.86

 

$

17.23

 

Portfolio and Investment Activity

For the three months ended March 31, 2026, the Company invested $243.2 million in 107 portfolio companies, including $123.6 million in 13 new companies, $110.6 million in 93 existing companies and $9.0 million in SLP. The Company had $255.4 million of principal repayments and sales in the quarter, resulting in net investment fundings of $(12.2) million.

Investment Activity for the Quarter Ended March 31, 2026:

($ in millions)

Q1 2026

 

Q4 2025

 

Investment Fundings

$

243.2

 

$

167.9

 

Sales and Repayments

$

255.4

 

$

193.2

 

Net Investment Activity

$

(12.2

)

$

(25.3

)

As of March 31, 2026, the Company’s investment portfolio had a fair value of $2,470.8 million, comprised of investments in 212 portfolio companies operating across 30 different industries.

Investment Portfolio at Fair Value as of March 31, 2026:

Investment Type

$ in Millions

 

% of Total

 

First Lien Senior Secured Loan

$

1,631.1

 

 

66.0

%

Second Lien Senior Secured Loan

 

30.1

 

 

1.2

 

Subordinated Debt

 

81.7

 

 

3.3

 

Preferred Equity

 

165.1

 

 

6.7

 

Equity Interest

167.3

 

 

6.8

 

Warrants

 

0.8

 

 

0.0

 

Investment Vehicles

 

394.7

 

 

16.0

 

Subordinated Note in ISLP

 

190.7

 

 

7.7

 

Equity Interest in ISLP

 

31.6

 

 

1.3

 

Subordinated Note in SLP

 

166.9

 

 

6.8

 

Preferred and Equity Interest in SLP

 

5.5

 

 

0.2

 

Total

$

2,470.8

 

 

100.0

%

As of March 31, 2026, the weighted average yield on the investment portfolio at amortized cost and fair value were 10.8% and 10.9%, respectively, as compared to 10.8% and 10.9%, respectively, as of December 31, 2025(4)(5). 92.6% of the Company’s debt investments at fair value were in floating rate securities.

As of March 31, 2026, six portfolio companies were on non-accrual status, representing 1.4% and 0.6% of the total investment portfolio at amortized cost and fair value, respectively.

As of March 31, 2026, ISLP’s investment portfolio had an aggregate fair value of $711.9 million, comprised of investments in 40 portfolio companies operating across 17 different industries. The investment portfolio on a fair value basis was comprised of 94.0% first lien senior secured loans, 0.7% second lien senior secured loans and 5.3% equity interests. 100% of ISLP’s debt investments at fair value were in floating rate securities.

As of March 31, 2026, SLP’s investment portfolio had an aggregate fair value of $1,599.1 million, comprised of investments in 106 portfolio companies operating across 26 different industries. The investment portfolio on a fair value basis was comprised of 99.7% first lien senior secured loans and 0.3% second lien senior secured loans. 100.0% of SLP’s debt investments at fair value were in floating rate securities.

Results of Operations

For the three months ended March 31, 2026 and December 31, 2025, total investment income was $66.2 million and $68.2 million, respectively.

Total expenses (before taxes) for the three months ended March 31, 2026 and December 31, 2025 were $37.9 million and $37.7 million, respectively.

Net investment income for the three months ended March 31, 2026 and December 31, 2025 was $27.4 million or $0.42 per share and $29.7 million or $0.46 per share, respectively.

During the three months ended March 31, 2026, the Company had net realized and unrealized losses of $24.0 million.

Net increase in net assets resulting from operations for the three months ended March 31, 2026 was $3.4 million, or $0.05 per share.

Capital and Liquidity

As of March 31, 2026, the Company had total principal debt outstanding of $1,467.0 million, including $195.0 million outstanding in the Company’s Sumitomo Credit Facility, $272.0 million outstanding of the debt issued through BCC Middle Market CLO 2019-1 LLC, $300.0 million outstanding in the Company’s senior unsecured notes due October 2026, $350.0 million outstanding in the Company's senior unsecured notes due March 2030, and $350.0 million outstanding in the Company's senior unsecured notes due March 2031.

For the three months ended March 31, 2026, the weighted average interest rate on debt outstanding was 4.6%, as compared to 4.6% for the three months ended December 31, 2025.

As of March 31, 2026, the Company had cash and cash equivalents (including foreign cash) of $16.6 million, restricted cash and cash equivalents of $17.6 million, $34.6 million of unsettled trades, net of receivables and payables of investments, and $660.0 million of capacity under its Sumitomo Credit Facility. As of March 31, 2026, the Company had $442.6 million of undrawn investment commitments.

As of March 31, 2026, the Company’s debt-to-equity and net debt-to-equity ratios were 1.34x and 1.28x, respectively, as compared to 1.32x and 1.24x, respectively, as of December 31, 2025(3).

Endnotes

(1)

Net investment income yields and net income returns are calculated on average net assets, or book value, for the respective periods shown.

(2)

Net debt-to-equity represents principal debt outstanding less cash and cash equivalents and unsettled trades, net of receivables and payables of investments.

(3)

The second quarter dividend is payable on June 29, 2026 to stockholders of record as of June 15, 2026.

(4)

The weighted average yield is computed as (a) the annual stated interest rate or yield earned on the relevant accruing debt and other income producing securities plus amortization of fees and discounts on the performing debt and other income producing investments, divided by (b) the total relevant investments at amortized cost or fair value. The weighted average yield does not represent the total return to our stockholders.

(5)

For non-stated rate income producing investments, computed based on (a) the dividend or interest income earned for the respective trailing twelve months ended on the measurement date, divided by (b) the ending amortized cost or fair value, as applicable. In instances where historical dividend or interest income data is not available or not representative for the trailing twelve months ended, the dividend or interest income is annualized.

Conference Call Information

A conference call to discuss the Company’s financial results will be held live at 8:30 a.m. Eastern Time on May 12, 2026. Please visit BCSF’s webcast link located on the Events & Presentations page of the Investor Resources section of BCSF’s website at http://www.baincapitalspecialtyfinance.com for a slide presentation that complements the Earnings Conference Call.

  • Participants are also invited to access the conference call by dialing one of the following numbers:
  • Domestic: 1-800-245-3047
  • International: 1-203-518-9765
  • Conference ID: BAIN

All participants will need to reference “Bain Capital Specialty Finance - First Quarter Ended March 31, 2026 Earnings Conference Call” once connected with the operator. All participants are asked to dial in 10-15 minutes prior to the call.

Replay Information:

An archived replay will be available approximately three hours after the conference call concludes through May 26, 2026 via a webcast link located on the Investor Resources section of BCSF’s website, and via the dial-in numbers listed below:

  • Domestic: 1-844-512-2921
  • International: 1-412-317-6671
  • Conference ID: 11161743

Bain Capital Specialty Finance, Inc.

Consolidated Statements of Assets and Liabilities

(in thousands, except share and per share data)

 

 

 

As of

 

 

As of

 

 

 

March 31, 2026

 

 

December 31, 2025

 

 

 

(Unaudited)

 

 

 

 

 

Assets

 

 

 

 

 

 

 

 

Investments at fair value:

 

 

 

 

 

 

 

 

Non-controlled/non-affiliate investments (amortized cost of $1,925,871 and $1,891,513, respectively)

 

$

 

1,916,461

 

 

$

 

1,905,297

 

Non-controlled/affiliate investments (amortized cost of $7,504 and $7,504, respectively)

 

 

 

19,164

 

 

 

 

18,674

 

Controlled affiliate investments (amortized cost of $549,483 and $603,650, respectively)

 

 

 

535,173

 

 

 

 

584,470

 

Cash and cash equivalents

 

 

 

12,973

 

 

 

 

23,092

 

Foreign cash (cost of $3,026 and $2,477, respectively)

 

 

 

3,622

 

 

 

 

3,151

 

Restricted cash and cash equivalents

 

 

 

17,593

 

 

 

 

32,667

 

Collateral on derivatives

 

 

 

9,813

 

 

 

 

10,993

 

Deferred financing costs

 

 

 

3,285

 

 

 

 

3,543

 

Interest receivable on investments

 

 

 

35,091

 

 

 

 

38,023

 

Interest rate swap

 

 

 

4,979

 

 

 

 

7,976

 

Receivable for sales and paydowns of investments

 

 

 

38,101

 

 

 

 

28,856

 

Prepaid insurance

 

 

 

277

 

 

 

 

489

 

Unrealized appreciation on forward currency exchange contracts

 

 

 

224

 

 

 

 

 

Dividend receivable

 

 

 

4,920

 

 

 

 

5,354

 

Total Assets

 

$

 

2,601,676

 

 

$

 

2,662,585

 

 

 

 

 

 

 

 

 

 

Liabilities

 

 

 

 

 

 

 

 

Debt (net of unamortized debt issuance costs of $17,144 and $10,110, respectively)

 

$

 

1,454,657

 

 

$

 

1,470,796

 

Interest payable

 

 

 

10,910

 

 

 

 

12,376

 

Payable for investments purchased

 

 

 

3,527

 

 

 

 

2,110

 

Collateral payable on derivatives

 

 

 

4,760

 

 

 

 

12,907

 

Unrealized depreciation on forward currency exchange contracts

 

 

 

2,739

 

 

 

 

9,061

 

Base management fee payable

 

 

 

9,085

 

 

 

 

9,408

 

Incentive fee payable

 

 

 

5,618

 

 

 

 

5,877

 

Accounts payable and accrued expenses

 

 

 

16,825

 

 

 

 

12,910

 

Distributions payable

 

 

 

 

 

 

 

9,730

 

Total Liabilities

 

 

 

1,508,121

 

 

 

 

1,545,175

 

 

 

 

 

 

 

 

 

 

Commitments and Contingencies (See Note 10)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net Assets

 

 

 

 

 

 

 

 

Common stock, par value $0.001 per share, 100,000,000,000 and 100,000,000,000 shares authorized, 64,868,507 and 64,868,507 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively

 

 

 

65

 

 

 

 

65

 

Paid in capital in excess of par value

 

 

 

1,161,110

 

 

 

 

1,161,110

 

Total distributable loss

 

 

 

(67,620

)

 

 

 

(43,765

)

Total Net Assets

 

 

 

1,093,555

 

 

 

 

1,117,410

 

Total Liabilities and Total Net Assets

 

$

 

2,601,676

 

 

$

 

2,662,585

 

 

 

 

 

 

 

 

 

 

Net asset value per share

 

$

 

16.86

 

 

$

 

17.23

 

See Notes to Consolidated Financial Statements 

 
 
Bain Capital Specialty Finance, Inc.

Consolidated Statements of Operations

(in thousands, except share and per share data)

(Unaudited)

 

 

For the Three Months Ended March 31,

 

 

 

2026

 

 

 

2025

 

Income

 

 

 

 

 

 

 

Investment income from non-controlled/non-affiliate investments:

 

 

 

 

 

 

 

Interest from investments

$

 

39,333

 

 

$

 

41,672

 

Dividend income

 

 

619

 

 

 

 

1,725

 

PIK income

 

 

8,705

 

 

 

 

6,606

 

Other income

 

 

1,476

 

 

 

 

2,833

 

Total investment income from non-controlled/non-affiliate investments

 

 

50,133

 

 

 

 

52,836

 

 

 

 

 

 

 

 

 

Investment income from non-controlled/affiliate investments:

 

 

 

 

 

 

 

Interest from investments

 

 

2

 

 

 

 

8

 

PIK income

 

 

 

 

 

 

17

 

Other income

 

 

21

 

 

 

 

42

 

Total investment income from non-controlled/affiliate investments

 

 

23

 

 

 

 

67

 

 

 

 

 

 

 

 

 

Investment income from controlled affiliate investments:

 

 

 

 

 

 

 

Interest from investments

 

 

10,033

 

 

 

 

9,148

 

Dividend income

 

 

5,983

 

 

 

 

4,786

 

PIK income

 

 

2

 

 

 

 

2

 

Total investment income from controlled affiliate investments

 

 

16,018

 

 

 

 

13,936

 

Total investment income

 

 

66,174

 

 

 

 

66,839

 

 

 

 

 

 

 

 

 

Expenses

 

 

 

 

 

 

 

Interest and debt financing expenses

 

 

20,252

 

 

 

 

18,904

 

Base management fee

 

 

9,085

 

 

 

 

9,068

 

Incentive fee

 

 

5,618

 

 

 

 

2,222

 

Professional fees

 

 

700

 

 

 

 

714

 

Directors fees

 

 

180

 

 

 

 

174

 

Other general and administrative expenses

 

 

2,069

 

 

 

 

2,571

 

Total expenses, net of fee waivers

 

 

37,904

 

 

 

 

33,653

 

Net investment income before taxes

 

 

28,270

 

 

 

 

33,186

 

Income tax expense, including excise tax

 

 

906

 

 

 

 

1,076

 

Net investment income

 

 

27,364

 

 

 

 

32,110

 

 

 

 

 

 

 

 

 

Net realized and unrealized gains (losses)

 

 

 

 

 

 

 

Net realized gain (loss) on non-controlled/non-affiliate investments

 

 

3,820

 

 

 

 

(20,986

)

Net realized loss on non-controlled/affiliate investments

 

 

 

 

 

 

(2,967

)

Net realized loss on controlled affiliate investments

 

 

(13,448

)

 

 

 

 

Net realized gain (loss) on foreign currency transactions

 

 

66

 

 

 

 

(249

)

Net realized loss on forward currency exchange contracts

 

 

(2,989

)

 

 

 

(2,405

)

Net change in unrealized appreciation on foreign currency translation

 

 

(135

)

 

 

 

435

 

Net change in unrealized appreciation on forward currency exchange contracts

 

 

6,546

 

 

 

 

(2,073

)

Net change in unrealized appreciation on non-controlled/non-affiliate investments

 

 

(23,194

)

 

 

 

23,993

 

Net change in unrealized appreciation on non-controlled/affiliate investments

 

 

490

 

 

 

 

(1,866

)

Net change in unrealized appreciation on controlled affiliate investments

 

 

4,870

 

 

 

 

2,555

 

Total net loss

 

 

(23,974

)

 

 

 

(3,563

)

 

 

 

 

 

 

 

 

Net increase in net assets resulting from operations

$

 

3,390

 

 

$

 

28,547

 

 

 

 

 

 

 

 

 

Basic and diluted net investment income per share of common stock

$

 

0.42

 

 

$

 

0.50

 

Basic and diluted increase in net assets resulting from operations per share of common stock

$

 

0.05

 

 

$

 

0.44

 

Basic and diluted weighted average common stock outstanding

 

 

64,868,507

 

 

 

 

64,676,192

 

 

See Notes to Consolidated Financial Statements

About Bain Capital Specialty Finance, Inc.

Bain Capital Specialty Finance, Inc. is an externally managed specialty finance company focused on lending to middle market companies. BCSF is managed by BCSF Advisors, LP, an SEC-registered investment adviser and a subsidiary of Bain Capital Credit, LP. Since commencing investment operations on October 13, 2016, and through March 31, 2026, BCSF has invested approximately $9,975.9 million in aggregate principal amount of debt and equity investments prior to any subsequent exits or repayments. BCSF’s investment objective is to generate current income and, to a lesser extent, capital appreciation through direct originations of secured debt, including first lien, first lien/last out, unitranche and second lien debt, investments in strategic joint ventures, equity investments and, to a lesser extent, corporate bonds. BCSF has elected to be regulated as a business development company under the Investment Company Act of 1940, as amended.

Forward-Looking Statements

This letter may contain “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Statements other than statements of historical facts included in this letter may constitute forward-looking statements and are not guarantees of future performance or results and involve a number of risks and uncertainties. Actual results may differ materially from those in the forward-looking statements as a result of a number of factors, including those described from time to time in filings with the U.S. Securities and Exchange Commission. The Company undertakes no duty to update any forward-looking statement made herein. All forward-looking statements speak only as of the date of this letter.

Contacts

Investor Contact:
Katherine Schneider
Tel. (212) 803-9613
investors@baincapitalbdc.com

Media Contact:
Scott Lessne
Tel. +1 (212) 300-1800
slessne@apcoworldwide.com

Bain Capital Specialty Finance, Inc.

NYSE:BCSF

Release Versions

Contacts

Investor Contact:
Katherine Schneider
Tel. (212) 803-9613
investors@baincapitalbdc.com

Media Contact:
Scott Lessne
Tel. +1 (212) 300-1800
slessne@apcoworldwide.com

More News From Bain Capital Specialty Finance, Inc.

Bain Capital Supports Growth of Kids2 with $225 Million Credit Facility

BOSTON--(BUSINESS WIRE)--Bain Capital today announced that its Private Credit Group acted as sole lender and administrative agent for a $225 million senior credit facility to Kids2, a global platform company that designs holistic solutions to help early-stage parents and families. The financing will support Kids2’s continued growth and global expansion. Headquartered in Atlanta, Georgia, with 12 offices around the world, Kids2’s diversified portfolio of brands - including Baby Einstein, Bright...

Bain Capital Specialty Finance, Inc. Schedules Earnings Release for the First Quarter Ended March 31, 2026

BOSTON--(BUSINESS WIRE)--Bain Capital Specialty Finance, Inc. (NYSE: BCSF, the “Company”) today announced it will report its financial results for the first quarter ended March 31, 2026 on Monday, May 11, 2026 after market close. Management will host a conference call on Tuesday, May 12, 2026 at 8:30 a.m. Eastern Time to discuss the Company’s financial results. Conference Call Information: A conference call to discuss the Company’s financial results will be held live at 8:30 a.m. Eastern Time o...

Bain Capital and Evergreen Medical Properties Acquire Portfolio of Six Medical Outpatient Facilities in Atlanta Metropolitan Area

ATLANTA & BOSTON--(BUSINESS WIRE)--Bain Capital's Real Estate team ("Bain Capital") and Evergreen Medical Properties (“Evergreen”) today announced the acquisition of a medical outpatient building portfolio consisting of six assets totaling approximately 665,000 square feet in the Atlanta metropolitan area. The private, off-market purchase was completed via a partnership between Bain Capital and Evergreen that focuses on acquiring, renovating, and operating mission-critical medical outpatient bu...
Back to Newsroom